6-fluoro-2-methyl-3-nitropyridine

We are 6-fluoro-2-methyl-3-nitropyridine CAS:18605-16-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: 6-fluoro-2-methyl-3-nitropyridine
CAS.NO:18605-16-8
Synonyms:2-Fluor-5-nitro-6-methylpyridin;
6-fluoro-2-methyl-3-nitro-pyridine;
2-FLUORO-5-NITRO-6-PICOLINE;
2-Fluoro-6-methyl-5-nitropyridine;
2-Fluoro-5-nitro-6-methylpyridine;
Molecular Formula:C6H5FN2O2
Molecular Weight:156.11500
 
Physical and Chemical Properties:
Density:1.357 g/mL at 25 °C(lit.)
Melting point:/
Boiling point: 233ºC at 760 mmHg
Flash point:94.7ºC
Index of Refraction: 1.538
 
Specification:
Appearance: White Crystalline Powder
Purity:≥99.0%
 
Packing:25 KGS/Drum
Storage:Store in a tightly closed container. Store in a cool, dry.
Application:    used to Pharmaceutical intermediate

6-fluoro-2-methyl-3-nitropyridine


Related News: There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space.2-Chloro-6-fluorobenzaldehyde CAS:387-45-1 There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space.Clorhidrato de bencilo (2S, 3aR, 7aS) -octahidroindol-2-carboxilato CAS:87679-38-7 In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum.Polysiloxanes di-Me Me hydrogen CAS:68037-59-2 Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.

Related Products
Product Name
Glycine ethyl ester hydrochloride View Details
ethyl 3-methylthiopropionate View Details
Tetraethylammonium bromide View Details
L-histydyl-L-leucine manufacturer Andrographolide Cas:5508-58-7 manufacturer 4-Iodobenzotrifluoride manufacturer N(α)-t-butoxycarbonyl-L-leucine manufacturer Kassinin manufacturer